| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |